Average Co-Inventor Count = 4.52
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Compass Therapeutics LLC (12 from 13 patents)
2. Xilio Development, Inc. (1 from 8 patents)
13 patents:
1. 12286483 - Method of treating cancer using CD137 antibodies and PD-1 antagonists
2. 12280120 - Tumor-specific cleavable linkers
3. 11970538 - Multispecific binding constructs against checkpoint molecules and uses thereof
4. 11851497 - CD137 antibodies and tumor antigen-targeting antibodies and uses thereof
5. 11752207 - Agonist antibodies that bind human CD137 and uses thereof
6. 11718679 - CD137 antibodies and PD-1 antagonists and uses thereof
7. 11046769 - Multispecific binding constructs against checkpoint molecules and uses thereof
8. 10716851 - Agonist antibodies that bind human CD137 and uses thereof
9. 10434175 - Agonist antibodies that bind human CD137 and uses thereof
10. 10350292 - Agonist antibodies that bind human CD137 and uses thereof
11. 10279038 - Agonist antibodies that bind human CD137 and uses thereof
12. 10279039 - Agonist antibodies that bind human CD137 and uses thereof
13. 10279040 - Agonist antibodies that bind human CD137 and uses thereof